Skip to content

Trypticasein Soy LAB-AGAR™

by BioMaxima Spółka Akcyjna Poland EUDAMED

Ref PW 3062 EMDN W0104010206

Regulatory status

as of 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR Number59026439ASTSAQ9 Basic UDI-DIDate5 Nov 2025RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/IVDR Active

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 24 Oct 2026

Device Name
Trypticasein Soy LAB-AGAR™ (TSA)
Model / Reference
PW 3062
Primary DI / UDI-DI
05902643940338
Basic UDI-DI
59026439ASTSAQ9
EMDN Code
W0104010206 Media in tubes (solid & liquid)
Device Class
Class A
Market of Registration
Poland

Manufacturer details

EUDAMED SRN
PL-MF-000039473

Other devices from BioMaxima Spółka Akcyjna

See all devices from BioMaxima Spółka Akcyjna →

Properties & raw data

Show properties, registry sources and raw records
  • Professional Testing
Other properties (10)
  • Sterile: No
  • Human Tissues: No
  • Animal Tissues: No
  • Microbial Substances: No
  • Reagent: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No
  • New Device: No

Sources (1)

  • EUDAMED 05902643940338|59026439ASTSAQ9 61 fields · synced 24 Oct 2026